[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance

Search:


View post   

>> No.11308136 [View]
File: 118 KB, 850x787, 1529704876660.jpg [View same] [iqdb] [saucenao] [google]
11308136

>>11308094
anime -> traps (pretending they're women) -> traps (acknowledging they're men) -> twinks -> men

>> No.11030006 [DELETED]  [View]
File: 118 KB, 850x787, 1529704876660.jpg [View same] [iqdb] [saucenao] [google]
11030006

>>11029836
GALT, which produces drugs for cancer and NASH
Its current most promising drug, GD-MR-02, has been shown to be very effective in treating NASH (an unmet medical need potentially worth millions) and has additionally delivered promising data in cancer immunotherapy
There are multiple catalysts coming in cohort 3 cancer data (likely to be positive, based on the results in cohorts 1 and 2), phase 3 NASH trials, and a potential buyout or partnership
Its price is being held down by short selling, mediocre PR from management, and an extended period without news
Despite these things, the science supporting GD-MR-02 is undeniably promising, and it's currently in a good entry position based on technical analysis

https://seekingalpha.com/article/4202616-nash-cirrhosis-real-nash-epidemic
https://www.tradingview.com/symbols/NASDAQ-GALT/

Navigation
View posts[+24][+48][+96]